CORE B: CLINICAL RESOURCES CORE The clinical spectrum of parkinsonian disorders is varied and may represent a continuum of inter-related phenotypes with common etiologic factors. While the diagnosis of the most common form, Parkinson disease (PD) may be relatively straightforward, discriminating PD from other variations of the phenotype can be challenging. Several forms of parkinsonism demonstrate extensive clinical overlap, which can interfere with accurate diagnosis. Since the power of genetic studies relies heavily on the accuracy of diagnoses, it is important that clinicians with special interest and training in movement disorders be involved in diagnosing patients for these studies. The differential diagnosis of PD includes many disorders that can mimic aspects of PD, including essential tremor;drug-induced parkinsonism;other secondary parkinsonian syndromes (vascular parkinsonism, tumors and other mass lesions of the basal ganglia);normal pressure hydrocephalus;and other atypical parkinsonian syndromes ("Parkinson plus") including progressive supranuclear palsy (PSP), multiple system atrophy (MSA), cortical basal degeneration (CBD). Some of these conditions (such as essential tremor or REM Sleep Behavior disorder) may represent early manifestations of a disease process leading to parkinsonism or PD. Expert evaluation by a movement disorders specialist and post-mortem neuropathologic diagnosis enhances accurate diagnosis of participants in genetic studies. This core builds on the clinical assessment expertise developed over the previous twelve years. While the main goal of is to provide resources for Udall Center projects, the clinical data, DNA samples and tissue resources collected will benefit other Udall Centers and PD researchers as well. Specifically, the core will provide the following services: 1) Enroll new participants and collect samples on existing participants as needed to support biomarker studies;2) Continue the longitudinal study of individuals with parkinsonism and unaffected controls participating in the tissue donation program;3) Continue operating the Udall Center Brain Bank.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS071674-05
Application #
8740571
Study Section
Special Emphasis Panel (ZNS1-SRB-E)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
$201,295
Indirect Cost
$68,880
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Alcalay, Roy N; Caccappolo, Elise; Mejia-Santana, Helen et al. (2014) Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol 71:62-7
Nuytemans, Karen; Inchausti, Vanessa; Beecham, Gary W et al. (2014) Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Mov Disord 29:827-30
Nalls, Mike A; Pankratz, Nathan; Lill, Christina M et al. (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 46:989-93
Huang, Anhui; Martin, Eden R; Vance, Jeffery M et al. (2014) Detecting genetic interactions in pathway-based genome-wide association studies. Genet Epidemiol 38:300-9
Wang, Liyong; Nuytemans, Karen; Bademci, Guney et al. (2013) High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2. Hum Mutat 34:1071-4
Nuytemans, Karen; Bademci, Guney; Inchausti, Vanessa et al. (2013) Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology 80:982-9
Hedges, Dale J; Guettouche, Toumy; Yang, Shan et al. (2011) Comparison of three targeted enrichment strategies on the SOLiD sequencing platform. PLoS One 6:e18595
Williams, Sion L; Huang, Jia; Edwards, Yvonne J K et al. (2010) The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers. Cell Metab 12:675-82